Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience

This publication has 30 references indexed in Scilit:

• Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study
  BMC Cancer, 2013
• Global Patterns of Cancer Incidence and Mortality Rates and Trends
  Cancer Epidemiology, Biomarkers & Prevention, 2010
• Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer
  Oncology, 2010
• Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
  Clinical Cancer Research, 2009
• New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  European Journal of Cancer, 2009
• Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
  Journal of Clinical Oncology, 2008
• Weekly Docetaxel and Prednisolone versus Prednisolone Alone in Androgen-Independent Prostate Cancer: A Randomized Phase II Study
  European Urology, 2007
• Chemotherapy for older patients with prostate cancer
  BJU International, 2006
• Are Older French Patients As Willing As Older American Patients to Undertake Chemotherapy?
  Journal of Clinical Oncology, 2003
• The physical activity scale for the elderly (PASE): Development and evaluation
  Journal of Clinical Epidemiology, 1993